Q’Apel Medical Raises $22 Million: Funds Will Help Grow a Highly Innovative Neurovascular Access Platform
In addition, Q'Apel Medical reported that Scott Huennekens, former Chairman, CEO and President of Verb Surgical, and Carter McNabb, Managing Director, River Cities Capital, will join the Board of Directors.